The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria

Erstveröffentlichung
2022
Authors
Kulasekararaj, Austin G.
Brodsky, Robert A.
Nishimura, Jun-ichi
Patriquin, Christopher J.
Schrezenmeier, Hubert
Wissenschaftlicher Artikel


Published in
Therapeutic Advances in Hematology ; 13 (2022). - ISSN 2040-6207. - eISSN 2040-6215
Link to publication
https://dx.doi.org/10.1177/20406207221091046
Institutions
UKU. Institut für Transfusionsmedizin
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
Subject headings
[Free subject headings]: C5 | complement system | eculizumab | hemolysis | paroxysmal nocturnal hemoglobinuria | ravulizumab | STEM-CELL TRANSPLANTATION | ECULIZUMAB TREATMENT | NATURAL-HISTORY | PNH | THERAPEUTICS | THROMBOSIS | SYMPTOMS | EFFICACY | THERAPY
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record